Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors - PubMed (original) (raw)

Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors

T J Liang et al. J Clin Invest. 1996.

Abstract

Receptor tyrosine kinases are important in cell signal transduction and proliferation. Abnormal expression of tyrosine kinases often leads to malignant transformation. C-met is a tyrosine kinase receptor and its ligand is hepatocyte growth factor (HGF). HGF/c-met plays diverse role in regulation of cell growth, shape and movement. Constitutively activated met, such as tpr-met, is a potent oncogene in vitro, but its carcinogenic role in vivo remains unclear. Our study demonstrates that expression of tpr-met leads to development of mammary tumors and other malignancies in transgenic mice, and suggests that deregulated met expression may be involved in mammary carcinogenesis.

PubMed Disclaimer

Cited by

Knockdown of RON receptor kinase delays but does not prevent tumor progression while enhancing HGF/MET signaling in pancreatic cancer cell lines.
Zhao S, Cao L, Freeman JW. Zhao S, et al. Oncogenesis. 2013 Oct 7;2(10):e76. doi: 10.1038/oncsis.2013.36. Oncogenesis. 2013. PMID: 24100611 Free PMC article.
Mammary fibroblast-derived hepatocyte growth factor stimulates growth and morphogenesis of mouse mammary tumor cells in primary culture.
Sasaki M, Nishio M, Tsukada Y, Enami J. Sasaki M, et al. Jpn J Cancer Res. 1998 Nov;89(11):1134-43. doi: 10.1111/j.1349-7006.1998.tb00508.x. Jpn J Cancer Res. 1998. PMID: 9914782 Free PMC article.
Mutation-introduced dimerization of receptor tyrosine kinases: from protein structure aberrations to carcinogenesis.
Hu H, Liu Y, Jiang T. Hu H, et al. Tumour Biol. 2015 Mar;36(3):1423-8. doi: 10.1007/s13277-015-3287-4. Epub 2015 Mar 7. Tumour Biol. 2015. PMID: 25750036 Review.
Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression.
Skrzypek K, Kusienicka A, Szewczyk B, Adamus T, Lukasiewicz E, Miekus K, Majka M. Skrzypek K, et al. Oncotarget. 2015 Oct 13;6(31):31378-98. doi: 10.18632/oncotarget.5145. Oncotarget. 2015. PMID: 26384300 Free PMC article.
An overview of the c-MET signaling pathway.
Organ SL, Tsao MS. Organ SL, et al. Ther Adv Med Oncol. 2011 Nov;3(1 Suppl):S7-S19. doi: 10.1177/1758834011422556. Ther Adv Med Oncol. 2011. PMID: 22128289 Free PMC article.

References

1. Cell. 1985 May;41(1):211-9 - PubMed
1. Hepatology. 1995 Jun;21(6):1543-6 - PubMed
1. Cell. 1986 Jun 20;45(6):895-904 - PubMed
1. Proc Natl Acad Sci U S A. 1987 Sep;84(18):6379-83 - PubMed
1. Oncogene. 1987 May;1(2):229-33 - PubMed

Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors - PubMed (original) (raw)